Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling

Developmental Biology

Volumn 262, Issue 2, 2003, Pages 225-241

  Haigh, Jody J ^a   Morelli, Paula I ^b   Gerhardt, Holger ^b   Haigh, Katharina ^a   Tsien, John ^a   Damert, Annette ^a,f   Miquerol, Lucile ^a,g   Muhlner, Ulrich ^c   Klein, Rudiger ^d   Ferrara, Napoleone ^e   Wagner, Erwin F ^c   Betsholtz, Christer ^b   Nagy, Andras ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^e GENENTECH INC   (United States)

^f PAUL EHRLICH INSTITUT   (Germany)

^g AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Blood vessel; Conditional gene inactivation; Cortex; Cre recombinase; Endothelium; Nervous system; Retina; VEGF A

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD VESSEL; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; DENSITY; EMBRYO; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REDUCTION; RETINA; RETINA INJURY; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENE; VASCULARIZATION;

EID: 0141503519     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0012-1606(03)00356-7     Document Type: Article

References (51)

1. Adams R.H., Klein R. Eph receptors and ephrin ligands essential mediators of vascular development . Trends Cardiovasc. Med. 10:2000;183-188.
2. Banasiak K.J., Xia Y., Haddad G.G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog. Neurobiol. 62:2000;215-249.
3. Behrens A., Haigh J., Mechta-Grigoriou F., Nagy A., Yaniv M., Wagner E.F. Impaired intervertebral disc formation in the absence of Jun. Development. 130:2003;103-109.
4. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 114:1992;521-532.
5. Carmeliet P., Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol. 237:1999;133-158.
6. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
7. Carmeliet P., Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system implications for neurological disorders . Semin. Cell Dev. Biol. 13:2002;39-53.
8. Damert A., Miquerol L., Gertsenstein M., Risau W., Nagy A. Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development. 129:2002;1881-1892.
9. Dor Y., Porat R., Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am. J. Physiol. Cell Physiol. 280:2001;C1367-C1374.
10. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development . Dev. Dyn. 203:1995;80-92.
11. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis therapeutic implications . Semin. Oncol. 29:2002;10-14.
12. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
13. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
14. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., Wright B.D., Radtke F., Aguet M., Ferrara N. VEGF is required for growth and survival in neonatal mice. Development. 126:1999;1149-1159.
15. Haigh J., McVeigh J., Greer P. The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network. Cell Growth Differ. 7:1996;931-944.
16. Hobson M.I., Green C.J., Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J. Anat. 197:(Pt 4):2000;591-605.
17. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 99:2002;11946-11950.
18. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor direct neuroprotective effect in in vitro ischemia . Proc. Natl. Acad. Sci. USA. 97:2000;10242-10247.
19. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development. 126:1999;4895-4902.
20. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice a new model for endothelial cell-lineage analysis in vivo . Dev. Biol. 230:2001;230-242.
21. Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3:2002;475-486.
22. Lee Y.M., Jeong C.H., Koo S.Y., Son M.J., Song H.S., Bae S.K., Raleigh J.A., Chung H.Y., Yoo M.A., Kim K.W. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo a possible signal for vessel development . Dev. Dyn. 220:2001;175-186.
23. Louissaint A. Jr., Rao S., Leventhal C., Goldman S.A. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 34:2002;945-960.
24. Lu M., Adamis A.P. Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol. Clin. North Am. 15:2002;69-79.
25. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., Mitsuda N., Tohyama M. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity signal transduction cascades . FASEB J. 15:2001;1218-1220.
26. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
27. Miquerol L., Gertsenstein M., Harpal K., Rossant J., Nagy A. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 212:1999;307-322.
28. Muhlner U., Mohle-Steinlein U., Wizigmann-Voos S., Christofori G., Risau W., Wagner E.F. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene. Oncogene. 18:1999;4200-4210.
29. Neufeld G., Cohen T., Shraga N., Lange T., Kessler O., Herzog Y. The neuropilins multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis . Trends Cardiovasc. Med. 12:2002;13-19.
30. Ng Y.S., Rohan R., Sunday M.E., Demello D.E., D'Amore P.A. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. 220:2001;112-121.
31. Novak A., Guo C., Yang W., Nagy A., Lobe C.G. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 28:2000;147-155.
32. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., Madri J.A., Ment L.R. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277:2002;11410-11415.
33. Ogunshola O.O., Stewart W.B., Mihalcik V., Solli T., Madri J.A., Ment L.R. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain Res. 119:2000;139-153.
34. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:2001;131-138.
35. Orioli D., Klein R. The Eph receptor family axonal guidance by contact repulsion . Trends Genet. 13:1997;354-359.
36. Palmer T.D. Adult neurogenesis and the vascular Nietzsche. Neuron. 34:2002;856-858.
37. Palmer T.D., Willhoite A.R., Gage F.H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425:2000;479-494.
38. Provis J.M., Leech J., Diaz C.M., Penfold P.L., Stone J., Keshet E. Development of the human retinal vasculature cellular relations and VEGF expression . Exp. Eye Res. 65:1997;555-568.
39. Robinson G.S., Ju M., Shih S.C., Xu X., McMahon G., Caldwell R.B., Smith L.E. Nonvascular role for VEGF VEGFR-1, 2 activity is critical for neural retinal development . FASEB J. 15:2001;1215-1217.
40. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., Betsholtz C., Shima D.T. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16:2002;2684-2698.
41. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:2001;167-171.
42. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
43. Shima D.T., Mailhos C. Vascular developmental biology getting nervous . Curr. Opin. Genet. Dev. 10:2000;536-542.
44. Smith L.E. Pathogenesis of retinopathy of prematurity. Acta Paediatr. Suppl. 91:2002;26-28.
45. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-I is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
46. Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12:2000;4243-4254.
47. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:2002;327-336.
48. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
49. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23:1999;99-103.
50. Varia M.A., Calkins-Adams D.P., Rinker L.H., Kennedy A.S., Novotny D.B., Fowler W.C. Jr., Raleigh J.A. Pimonidazole a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma . Gynecol. Oncol. 71:1998;270-277.
51. Zelzer E., McLean W., Ng Y.S., Fukai N., Reginato A.M., Lovejoy S., D'Amore P.A., Olsen B.R. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 129:2002;1893-1904.